SS
NIVF

SBI Securities’s NewGenIvf NIVF Stock Holding History

SBI Securities’s Portfolio NIVF Stock Details NIVF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62 Buy
38
+36
+1,800% +$139 ﹤0.01% 3626
2026
Q1 		$11 Hold
2
– – ﹤0.01% 3846
2025
Q4 		$43 Hold
2
– – ﹤0.01% 3609
2025
Q3 		$558 Buy
+2
New +$840 ﹤0.01% 2926
2025
Q2 		– Hold
0
– – – 4018
2025
Q1 		– Hold
0
– -$406 – 4216
2024
Q4 		– Hold
0
– – – 2971

Other funds holding NIVF

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities's NIVF Position: Q2 2026 in Review

SBI Securities increased its NewGenIvf (NIVF) stake by 1,800% in Q2 2026, buying an estimated $139 and bringing the position to 38 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #3626.

SBI Securities first reported a position in NIVF in Q3 2025 and has held it in 4 quarters since. The position peaked at $558 in Q3 2025. 5 funds tracked by Wall St. Rank hold NIVF as of Q2 2026.

  • SBI Securities held 38 shares of NewGenIvf worth $62 as of Q2 2026.
  • SBI Securities bought 36 NewGenIvf shares in Q2 2026, an estimated $139.
  • NewGenIvf made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3626 holding.
  • SBI Securities first reported a position in NewGenIvf in Q3 2025 and has held it in 4 quarters since.
  • SBI Securities's NewGenIvf position peaked at $558 in Q3 2025.
  • 5 funds tracked by Wall St. Rank held NewGenIvf as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.